DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Bethesda North Marriott Hotel and Conference Center

2023 年 02 月 13 日 11:30 上午 - 2023 年 02 月 15 日 2:15 下午

5701 Marinelli Road, , North Bethesda, MD 20852 , USA

Regulatory Submissions, Information, and Document Management Forum

Sponsored Session: Case Study hosted by IQVIA: Reduce Time, Cost, and Risk, from Drug Discovery Through Post-Registration

Session Chair(s)

  Sponsored Sessions

Sponsored Sessions

United States

Reduce Time, Cost, and Risk, from Drug Discovery Through Post-Registration

Life sciences organizations are often strained by the demand of regulatory complexity and maintaining compliance in different geographies. In addition, keeping up with the ever-changing regulatory landscape can be time-consuming and costly in the drug development continuum.

Learn how IQVIA’s Regulatory Affairs and Drug Development Solutions (RADDS) provides data-driven strategic drug development and technology-enabled services to drive efficiency in regulatory affairs, operations, submissions, and regulatory intelligence along the entire lifecycle of the product.

Featured Topics:
  • Regulatory strategy across the entire drug development continuum
  • Maximize early strategic advantages to enable operational efficiency
  • Enhance regulatory affairs from pre-registration to post-registration
  • Use AI/ML and regulatory intelligence tools to lower administrative burdens

Speaker(s)

Michelle  Gyzen

Instructor

Michelle Gyzen

IQVIA, United States

Sr. Director, Strategic Solutions - Regulatory Affairs & Drug Development

Michel Francois Denarie, MBA

Instructor

Michel Francois Denarie, MBA

IQVIA, United States

Senior Principal, Regulatory Affairs and Drug Development Solutions

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。